Global Health Data Exchange - Discover the World's Health Data

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

Nav

General Info
Geography 
Austria (AUT)
Belgium (BEL)
Bulgaria (BGR)
Czechia (CZE)
Estonia (EST)
France (FRA)
Germany (DEU)
Hungary (HUN)
Italy (ITA)
Latvia (LVA)
Poland (POL)
Portugal (PRT)
Romania (ROU)
Slovakia (SVK)
Spain (ESP)
Ukraine (UKR)
Time period covered 
01/2004 - 12/2009
Citation
Authors 
Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators
Journal 
N Engl J Med
Volume 
364
Issue 
10
Pages 
907-17
Publication year 
2011
Suggested citation 
Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011; 364(10): 907-17.